Marker Therapeutics Inc.

NASDAQ: MRKR · Real-Time Price · USD
1.24
-0.01 (-0.80%)
At close: Aug 15, 2025, 3:59 PM
1.26
1.61%
After-hours: Aug 15, 2025, 07:16 PM EDT

Marker Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
19.19M 15.11M 11.78M 42.35M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a -17.8M n/a
Receivables
2.35M 1.03M 2.4M 237.00
Inventory
n/a -988.13K n/a n/a
Other Current Assets
483.72K 988.13K 585.84K 1.15M
Total Current Assets
22.02M 17.13M 16.62M 45.98M
Property-Plant & Equipment
n/a n/a 17.8M 22.15M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
n/a n/a 17.8M 22.15M
Total Assets
22.02M 17.13M 34.42M 68.14M
Account Payables
1.07M 961K 1.1M 5.14M
Deferred Revenue
n/a n/a 2.5M 1.15M
Short-Term Debt
n/a n/a n/a 620.49K
Other Current Liabilities
2.21M 1.84M 2.93M 3.32M
Total Current Liabilities
3.46M 3.07M 7.78M 12.9M
Long-Term Debt
n/a n/a n/a 11.25M
Other Long-Term Liabilities
n/a n/a n/a -11.25M
Total Long-Term Liabilities
n/a n/a 7.04M 11.25M
Total Liabilities
3.46M 3.07M 14.82M 24.15M
Total Debt
n/a n/a 7.62M 11.87M
Common Stock
10.71K 8.89K 8.41K 83.08K
Retained Earnings
-447.02M -436.29M -428.05M -398.12M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
18,558.4B 14.05M 19.6M 43.99M
Total Investments
19,192.4B n/a n/a n/a